D.E. Shaw & Co’s West Pharmaceutical WST Stock Holding History

D.E. Shaw & Co’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-10,000	Closed	-$3.02M	–	5571
2022 Q2	$3.02M	Hold	10,000	–	–	﹤0.01%	2700
2022 Q1	$4.11M	Sell	10,000 -15,400	-61%	-$6.03M	﹤0.01%	2546
2021 Q4	$11.9M	Buy	25,400 +17,600	+226%	+$7.58M	0.01%	1497
2021 Q3	$3.31M	Buy	+7,800	New	+$3.29M	﹤0.01%	2527
2020 Q1	–	Sell	-11,700	Closed	-$1.76M	–	4313
2019 Q4	$1.76M	Sell	11,700 -10,000	-46%	-$1.46M	﹤0.01%	2577
2019 Q3	$3.08M	Buy	21,700 +11,700	+117%	+$1.61M	﹤0.01%	2037
2019 Q2	$1.25M	Buy	+10,000	New	+$1.18M	﹤0.01%	2540

Other funds holding WST

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

D.E. Shaw & Co's WST Position: Q1 2026 in Review

D.E. Shaw & Co opened a new position in West Pharmaceutical (WST) in Q1 2026: 14,001 shares worth $3.51M. The stake represents ﹤0.01% of the portfolio and ranks #2452 among its holdings. This is a return to the name: D.E. Shaw & Co previously reported a position in WST as recently as Q3 2025.

D.E. Shaw & Co first reported a position in WST in Q2 2013 and has held it in 36 quarters since. The position peaked at $140M in Q4 2024. 753 funds tracked by Wall St. Rank hold WST as of Q1 2026.

D.E. Shaw & Co held 14,001 shares of West Pharmaceutical worth $3.51M as of Q1 2026.
West Pharmaceutical was a new D.E. Shaw & Co position in Q1 2026.
West Pharmaceutical made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2452 holding.
D.E. Shaw & Co first reported a position in West Pharmaceutical in Q2 2013 and has held it in 36 quarters since.
D.E. Shaw & Co's West Pharmaceutical position peaked at $140M in Q4 2024.
753 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.